CG Oncology Inc.

CG Oncology Inc. - ROEverified

CGON

Price:

$72.38

Market Cap:

$6.38B

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent;...[Read more]

Industry

Biotechnology

IPO Date

2024-01-25

Stock Exchange

NASDAQ

Ticker

CGON

The ROE as of August 2026 (TTM) for CG Oncology Inc. (CGON) is -23.33%

According to CG Oncology Inc.’s latest financial reports and current stock price. The company's current ROE is -23.33%. This represents a change of 296.13% compared to the average of -5.89% of the last 4 quarters.

CG Oncology Inc. (CGON) Historical ROE (quarterly & annually)

How has CGON ROE performed in the past?

The mean historical ROE of CG Oncology Inc. over the last ten years is -23.98%. The current -23.33% ROE has changed -2.74% with respect to the historical average. Over the past ten years (40 quarters), CGON's ROE was at its highest in in the June 2023 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -8.72%.

Quarterly (TTM)
Annual

Average

-23.98%

Median

-26.30%

Minimum

-31.90%

Maximum

-12.00%

CG Oncology Inc. (CGON) ROE by Quarter and Year

Discovering the peaks and valleys of CG Oncology Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 78.20%

Maximum Annual ROE = -12.00%

Minimum Annual Increase = -54.36%

Minimum Annual ROE = -31.90%

Quarterly (TTM)
Annual
YearROEChange
2025-21.39%78.20%
2024-12.00%-54.36%
2023-26.30%-7.10%
2022-28.31%-11.23%

CG Oncology Inc. (CGON) Average ROE

How has CGON ROE performed in the past?

The current ROE of CG Oncology Inc. (CGON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-19.90%

5-year avg

-23.98%

10-year avg

-23.98%

CG Oncology Inc. (CGON) ROE vs. Peers

How is CGON’s ROE compared to its peers?

CG Oncology Inc.’s ROE is greater than Celcuity Inc. (-244.61%), greater than Ascentage Pharma Group International (-123.61%), greater than Centessa Pharmaceuticals plc (-60.37%), greater than Apogee Therapeutics, Inc. (-32.64%), greater than Xenon Pharmaceuticals Inc. (-49.23%), greater than Travere Therapeutics, Inc. (-55.79%), less than Ultragenyx Pharmaceutical Inc. (397.00%), greater than Legend Biotech Corporation (-24.91%), greater than Disc Medicine, Inc. (-37.17%), greater than Tarsus Pharmaceuticals, Inc. (-14.19%),

Build a custom stock screener for CG Oncology Inc. (CGON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CG Oncology Inc. (CGON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CG Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is CG Oncology Inc.'s ROE?

How is the ROE calculated for CG Oncology Inc. (CGON)?

What is the highest ROE for CG Oncology Inc. (CGON)?

What is the 3-year average ROE for CG Oncology Inc. (CGON)?

What is the 5-year average ROE for CG Oncology Inc. (CGON)?

How does the current ROE for CG Oncology Inc. (CGON) compare to its historical average?